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Received February 15, 2012; accepted June 5, 2012AbstractBackground: Transarterial embolization is a standard method for management of direct carotid-cavernous fistula (DCCF). The purpose of this
study was to report our experiences, and immediate and long-term outcomes of endovascular embolization of DCCFs by using detachable coils
(DCs).
Methods: Over 8 years, 24 patients with 25 DCCFs underwent endovascular DC embolization. There were 15 men and nine women; age ranged
from 8 to 82 years (mean, 39 years). Immediate and long-term angiographic as well as clinical outcomes after endovascular DC embolization
were retrospectively analyzed. The number and the length of DCs used to occlude the fistula were also evaluated.
Results: Eighteen DCCFs were successfully occluded by single-session endovascular embolization with preservation of the parent artery.
Retreatments by transvenous (n ¼ 5) and/ or transorbital routes (n ¼ 3) had to be performed in seven patients because of residual fistula (n ¼ 4)
or recurrent fistula (n ¼ 4) occurring within 3 weeks after embolization. The average numbers and length of coils to occlude the fistulas were 14
(range, 2e31) and 189 cm (range, 16e756 cm), respectively. Four patients had small residual fistulas with spontaneous thrombosis on follow-up
angiography. Three patients had transient cranial nerve impairment of the third (n ¼ 1) or sixth (n ¼ 2) nerve. There was no significant
procedure-related neurological complication. The follow-up period was 3e48 months (mean, 19 months)
Conclusion: Endovascular DC embolization of DCCFs was proved both efficacious and safe in managing high-flow fistulas with sustained
angiographic and clinical effects, particularly in those DCCFs with small fistula track and/or cavernous sinus. However, retreatment via various
routes may be necessary in some patients because of residual or recurrent fistulas.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Direct carotid-cavernous fistula (DCCF) is a high-flow
arteriovenous fistula between the cavernous sinus (CS) and
internal carotid artery (ICA). It commonly results from
a traumatic tear or aneurysm rupture in the CS portion of the
ICA. DCCFs usually present with ocular-orbital venous* Corresponding author. Dr. Chao-Bao Luo, Department of Radiology, Tai-
pei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112,
Taiwan, ROC.
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1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.09.007congestion and cephalic bruit. The goal of treatment is to
occlude the fistula with preservation of the ICA flow. In the
past, transarterial balloon embolization of DCCFs was the
standard method and had promising results.1e3 Due to lack of
availability of detachable balloons, endovascular embolization
using DC has become the mainstay for management of
DCCFs. However, the immediate and long-term effect of DC
for DCCFs has not been thoroughly evaluated.4e7
The purpose of this study was to report our experience of
endovascular DC embolization in 24 patients with 25 DCCFs
and to evaluate the immediate and long-term effects of DC in
managing DCCFs.hinese Medical Association. All rights reserved.
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From October 2002 to September 2010, there were 24
patients with 25 DCCFs who were treated by endovascular DC
embolization. This study was approved by Institutional
Review board of Taipei Veterans General Hospital (IRB
201001003IA). The clinical data of the 24 patients are
summarized in Table 1. These patients included 15 men and
nine women, and their ages ranged from 8 to 82 years (mean
39 years). All patients had oculareorbital venous congestive
manifestations such as chemosis, bruit, and proptosis; three
presented with headache, one experienced neurologic deficit
because of intracerebral hemorrhage. Endovascular procedures
of DCCFs were performed under general anesthesia using
a femoral approach. Activated clotting time was maintained at
a value of twice the baseline value by intravenous adminis-
tration of heparin. A 6F or 7F guiding catheter was positioned
in the cervical ICA, followed by navigation of micro-
catheter(s) to the CS. Occlusion of the DCCFs was initiated by
selection of the proper DC; DCs were packed into the CS as
densely as possible. The endpoint of the procedures was
complete occlusion of the fistula flow (n ¼ 17) or slow fistula
flow with further coil embolization being impossible because
of recoil of microcatheter into the parent artery (n ¼ 8).
A postembolization angiogram was done immediately after
the completion of the procedure to check for occlusion of theTable 1
Demography and outcomes of endovascular detachable coil embolization in 24 pa
Patient/sex/
age (y)
DC number/
length
Adjuvant
embolic agent
Adjuvant
access route(s)
1/M/35 2/16 cm Nil Nil
2/F/24 13/234 cm Nil Nil
3/M/21 7/92 cm Nil Nil
4/F/56 6/78 cm Nil Nil
5/F/39 9/88 cm Nil Nil
6/30 cm
6/F/82 3/48 cm Nil Nil
7/M/23 7/88 cm Nil Nil
8/M/35 16/283 cm Nil Nil
9/M/67 8/96 cm Nil Nil
10/M/46 4/68 cm Nil Nil
11/F/24 11/134 cm Nil Nil
12/F/48 12/152 cm NBCA Nil
13/F/26 21/283 cm NBCA Transorbital
14/M/8 19/225 cm NBCA Transorbital
15/M/51 9/128 cm Nil Nil
16/F/62 15/238 cm Nil Nil
17/M/27 25/250 cm Nil Nil
18/M/59 24/299 cm Nil Nil
19/F/46 28/345 cm NBCA Trans-FV, transorbita
20/M/24 31/756 cm Nil Trans-FV
21/M/31 21/205 cm Nil Trans-FV, trans-IPS
22/M/34 15/189 cm Nil Trans-FV
23/M/18 16/175 cm NBCA Nil
24/M/57 14/235 cm Nil Nil
CN ¼ cranial nerve; FV ¼ facial vein; IPS ¼ inferior petrous sinus.fistula. Of these 25 DCCFs, 18 had follow-up with conven-
tional and/or magnetic resonance angiography to evaluate the
occluded fistula. All patients were followed-up clinically for
an average of 19 months (range, 3e48 months).
3. Results
Results and follow-up findings are listed in Table 1. The
average number and length of coils used were 14 (2e31) and
189 cm (16e756 cm), respectively, and largely depended on the
size of the fistula tract and CS. Complete fistula closures were
documented on immediate postembolization angiograms in 17
DCCFs (Fig. 1), whereas small residual flow remained in the
other eight and spontaneous thrombosis was confirmed in four
DCCFs by follow-up angiograms within 7 days. Retreatment
was necessary in four persistent residual (Fig. 2) and four
recurrent DCCFs (Figs. 2 and 3) occurring on Days 1, 2, 11 and
17, respectively, after embolization. All these eight recurrent
and/or residual fistulas were found in 16 larger CSs that needed
longer coils (>100 cm) to pack the CS and fistula. Conversely,
nine small fistulas with small CSs embolized by less coil length
(<100 cm) all were treated in a single session with fistula total
occlusion demonstrated by postembolization or follow-up
angiograms (Table 1). Transarterial balloon-assisted n-butyl-
2-cyanoacrylate (NBCA; Nycomed, Ingenor, Paris, France)
embolization was performed in two; transvenous DCtients with 25 direct carotid-cavernous fistulas.
Causes of adjuvant
embolic agent and/or
access route
Outcome Follow-up
(mo)
Cure 20
Cure 18
Residual fistula
with spontaneous cure
36
Cure 23
Cure/residual fistula
then spontaneous cure
18
Cure 25
Cure 36
Residual fistula with
spontaneous cure
28
Cure 32
Cure 19
Cure 14
Residual fistula Transient CN6 palsy 26
Recurrent fistula Cure 25
Residual fistula Transient CN6 palsy 16
Cure 9
Cure 19
Cure 5
Cure 18
l Residual and
recurrent fistulas
Transient CN3 palsy 17
Cure 7
Recurrent fistula Cure 16
Recurrent fistula Cure 6
Residual fistula Cure 4
Residual fistula then
spontaneous cure
3
Fig. 1. A 82-year-old woman had right DCCF with small fistula and cavernous sinus. (A) Right lateral carotid angiogram revealed a DCCF with small fistula track
(arrow) and small cavernous sinus (arrowheads). (B,C) Transarterial detachable coil (DC) embolization with total occlusion of the fistulae was achieved by the
placement of three DCs with total length of 48 cm of coils into the cavernous sinus (CS).
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inferior petrous sinus (n ¼ 1) was initiated in five, while three
underwent a transorbital approach (Fig. 2E) by usingNBCAand
DC embolization. After the last session of procedures, three
patients had temporary functional impairment of the sixth
(n ¼ 2) or third (n ¼ 1) cranial nerve, which may be related to
initial dense coil packing; this resolved completely within 6
months. No significant procedure-related neurological compli-
cation or recurrent fistula was observed in any of the 24 patients.
All the ocular-orbital symptoms and signs related to fistula such
as bruit, chemosis, proptosis, or headache gradually resolved
after the final endovascular treatment.
4. Discussion
DCCFs were usually treated with detachable balloon in the
past. By the high-flow fistula flow, the balloon could be guided
into the fistula and CS. Before detachment, the balloon could
be inflated by contrast media to a volume larger than theorifice of the fistula to block the fistula flow and to prevent its
retrograde herniation into the ICA. This method is relatively
simple and inexpensive in some cases. However, in those
patients with complex vascular and/or fistula anatomy such as
a tortuous, stenotic ICA, intimal flap, small fistula tract, or
a small CS, the balloon cannot be directed into an ideal
position such that the fistula is occluded with ICA preserva-
tion. Furthermore, the potential risks of detachable balloon in
these patients are premature balloon detachment with inad-
vertent occlusion of carotid artery or intracranial branches
leading to thromboembolic events.3
Placement of a cover stent is another treatment option. It
may immediately obliterate DCCFs by placing an imperme-
able barrier across the site of fistula communication. The
major advantage of the cover stent itself is the capability to
preserve the flow of the ICA by successful navigation and
deployment of the stent into the cavernous ICA to occlude the
tear.8 The disadvantages of this stent are its stiffness and larger
caliber, making it difficult to navigate into the distal ICA,
Fig. 2. A 46-year-old woman presented with right DCCFs. (A) Postembolization lateral carotid angiography demonstrated residual fistula with exclusive draining
to ophthalmic vein. (BeD) She underwent transfacial vein DC embolization with total occlusion of the fistula; unfortunately, she had recurrent fistula with anterior
and posterior drains. (E,F). Transorbital DC and NBCA embolization were performed with total occlusion of the fistula.
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residual or recurrent fistula may occur because of leaking of
fistula flow between the stent and the arterial wall. In addition,
dual anti-platelet regime to maintain the patency of the ICA is
necessary. So far, long-term safety data are lacking in use of
covered stents to treat the DCCFs.
The use of standard platinum coils alone has been reported
in the treatment of intracranial high-flow AVFs.10 By navi-
gating a microcatheter into the CS through the fistula tract,
microcoils can be placed into the CS, leading to fistula
occlusion. Technical pitfalls associated with embolization
done with these coils include the impossibility of easy
retrieval, the relative stiffness of the coils, the risk of perfo-
ration, and the difficulty of packing them tightly resulting in
residual fistula. DC, however, is retrievable and allows precise
coil placement; furthermore, DC has longer coils available
than conventional platinum coils. However, the disadvantages
of DC are that it is very expensive and not thrombogenic, and
a residual fistula may occur because of insufficient packing of
the fistula and CS. Furthermore, in DCCFs with larger CS,
many coils are needed and coil mass may superimpose with
the nearby parent artery, leading to difficulty in evaluating the
patency of the parent artery. To prevent coil herniation into the
parent artery, stent-assisted coil embolization had been re-
ported, this technique is particularly useful when the tear in
the ICA is large.11 DC was thought to be a far more suitable
embolic material for those DCCFs with small fistula tracts andsmall CS.4,5 Another major concern is the recurrent or residual
fistula, which may by reduced by the advent of the hydrogel
coil (Hydrocoil; MicroVention, Inc, Aliso Viejo, CA, USA).
By the expansion of the hydrogel attached to the coil, there is
higher packing density than conventional DC, and with lower
coil number and length requirements.12
In our series, DC was selected as a first line of embolic
material to occlude DCCFs. To achieve mechanical blockage
the shunting flow with angiographic cure of the DCCF, the CS
should be as densely packed as possible. However, recoil of
microcatheter from the CS into the ICA is not uncommon
during advancement of the coils into the CS because there is
less space in the CS in the late stage of embolization. In this
circumstance, recatheterization of the microcatheter into the
fistula/CS is difficult because of blockage by previously
detached coils. Another drawback of DC embolization is
recurrent fistula, which is particularly common in fistulas with
larger tears associated with a larger CS, because there is less
coil packing density compared with those of small fistula and
small CS. To treat these residual or recurrent fistulas, a trans-
venous route by direct occlusion of the venous drains is an
alternative. Transinferior petrous sinus and/or transfacial vein
can be selected, depending on whether the fistula drainage is
posterior or anterior, such as seen in Cases 19, 20, 22, and 23.
Another access route is via transorbit, by direct puncture of
superior ophthalmic vein or CS. A transorbital approach to
treat difficult fistula anatomy has been reported.13e15 In these
Fig. 3. A 24-year-old man presented with left DCCF with complete steal phenomenon. (A) Left frontal carotid angiogram shows a DCCF with large CS and with
complete steal of carotid blood flow; he also had a traumatic aneurysm in the cervical internal carotid artery (arrow). (B) A total of 29 DCs with total length of
756 cm were employed to occlude fistula, and CS resulted in total occlusion of the fistula with preservation of the ICA. (C) The patient had recurrent fistulas, which
was subsequently confirmed by carotid angiogram with drainage exclusively to the superior ophthalmic vein. (D,E) He underwent transfacial vein DC embolization
leading to total occlusion of the fistula.
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puncture of the CS in three patients. The potential risks of this
method are injury of the optic nerve and eyeball, intraorbital
hematoma formation, and difficulty to achieve hemostasis at
the end of procedure. Because it is more invasive and risky, it
should be performed by an experienced operator who is
familiar with the technique. Furthermore, this method is
reserved for those fistulas in which there has been failure to
achieve morphologic cure with preservation of ICA flow by
other routes. In our series, we selected NBCA as an adjuvant
embolic agent to treat recurrent (n ¼ 2) or residual (n ¼ 3)
fistulas. Under a protective balloon in the ICA, about 1e2 ml
50% NBCA/lipoidol mixture was slowly infused into the CS.
The advantages of NBCA are its low cost and quick formation
of thrombus with occlusion of the fistula. 16 However, it should
be used with caution and performed by experienced operators
because it is a liquid and it is difficult to control its flow during
infusion. Inadvertent leakage into the ICA results in cata-
strophic complications.
In our series, two to 31 coils (mean, 14) with an average
length of 189 cm were used to achieve angiographic cure. The
number and length of coils largely depended on the size of the
CS. In our series, subtotal or partial obliteration of the fistulae
with residual fistula was observed in eight DCCFs at the endof the procedure; of these, four showed spontaneous closure of
the residual fistula on follow-up angiogram 3e4 days after
embolization. Therefore, subtotal occlusion with small and/or
slow residual shunting flow may not indicate failure and does
not appear to be a definite indication for retreatment.
However, a follow-up angiogram is mandatory to check for
the occurrence of spontaneous thrombosis or larger residual
fistula.
In conclusion, transarterial DC embolization of DCCFs was
proved in both efficacy and safety for managing high-flow
AVFs with sustained effect, particularly in DCCFs with
a small fistula track and/or CS. However, retreatment via
various routes and/or embolic materials maybe necessary in
some DCCFs with larger fistula associated with larger CS
because of residual or recurrent fistulas. Meticulous evaluation
and understanding of the angioarchitecture of the fistula is
important to avoid cranial nerve palsies or incomplete occlu-
sion of the fistulas.
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